Global Hepatoprotective Drug Against Alcohol Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 109

Published Date: 06 Feb 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Hepatoprotective Drug Against Alcohol market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Hepatoprotective Drug Against Alcohol market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Hepatoprotective Drug Against Alcohol market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Hepatoprotective Drug Against Alcohol market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Hepatoprotective Drug Against Alcohol market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Hepatoprotective Drug Against Alcohol market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Hepatoprotective Drug Against Alcohol
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Hepatoprotective Drug Against Alcohol market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Livestamin Healthcare, The Himalaya Drug Company, Mysha Health World, Chambio and Noreva Biotech, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Hepatoprotective Drug Against Alcohol market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Based on Animal Ingredients
    Based on Plant Ingredients

Market segment by Application
    Pharmacy
    Hospital
    Dieticians Clinic
    Supermarket
    Others

Major players covered
    Livestamin Healthcare
    The Himalaya Drug Company
    Mysha Health World
    Chambio
    Noreva Biotech
    Finecure Pharmaceuticals Limited
    Iscon Life Sciences
    Sunflower Pharmaceutical Group Co.,ltd.
    Swisse
    By-health Co.,ltd
    Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd.
    Xiuzheng Pharmaceutical Industry Group Company

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Hepatoprotective Drug Against Alcohol product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Hepatoprotective Drug Against Alcohol, with price, sales, revenue and global market share of Hepatoprotective Drug Against Alcohol from 2018 to 2023.
Chapter 3, the Hepatoprotective Drug Against Alcohol competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hepatoprotective Drug Against Alcohol breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Hepatoprotective Drug Against Alcohol market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Hepatoprotective Drug Against Alcohol.
Chapter 14 and 15, to describe Hepatoprotective Drug Against Alcohol sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Hepatoprotective Drug Against Alcohol
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Hepatoprotective Drug Against Alcohol Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Based on Animal Ingredients
        1.3.3 Based on Plant Ingredients
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Hepatoprotective Drug Against Alcohol Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Pharmacy
        1.4.3 Hospital
        1.4.4 Dieticians Clinic
        1.4.5 Supermarket
        1.4.6 Others
    1.5 Global Hepatoprotective Drug Against Alcohol Market Size & Forecast
        1.5.1 Global Hepatoprotective Drug Against Alcohol Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Hepatoprotective Drug Against Alcohol Sales Quantity (2018-2029)
        1.5.3 Global Hepatoprotective Drug Against Alcohol Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 Livestamin Healthcare
        2.1.1 Livestamin Healthcare Details
        2.1.2 Livestamin Healthcare Major Business
        2.1.3 Livestamin Healthcare Hepatoprotective Drug Against Alcohol Product and Services
        2.1.4 Livestamin Healthcare Hepatoprotective Drug Against Alcohol Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Livestamin Healthcare Recent Developments/Updates
    2.2 The Himalaya Drug Company
        2.2.1 The Himalaya Drug Company Details
        2.2.2 The Himalaya Drug Company Major Business
        2.2.3 The Himalaya Drug Company Hepatoprotective Drug Against Alcohol Product and Services
        2.2.4 The Himalaya Drug Company Hepatoprotective Drug Against Alcohol Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 The Himalaya Drug Company Recent Developments/Updates
    2.3 Mysha Health World
        2.3.1 Mysha Health World Details
        2.3.2 Mysha Health World Major Business
        2.3.3 Mysha Health World Hepatoprotective Drug Against Alcohol Product and Services
        2.3.4 Mysha Health World Hepatoprotective Drug Against Alcohol Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Mysha Health World Recent Developments/Updates
    2.4 Chambio
        2.4.1 Chambio Details
        2.4.2 Chambio Major Business
        2.4.3 Chambio Hepatoprotective Drug Against Alcohol Product and Services
        2.4.4 Chambio Hepatoprotective Drug Against Alcohol Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Chambio Recent Developments/Updates
    2.5 Noreva Biotech
        2.5.1 Noreva Biotech Details
        2.5.2 Noreva Biotech Major Business
        2.5.3 Noreva Biotech Hepatoprotective Drug Against Alcohol Product and Services
        2.5.4 Noreva Biotech Hepatoprotective Drug Against Alcohol Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Noreva Biotech Recent Developments/Updates
    2.6 Finecure Pharmaceuticals Limited
        2.6.1 Finecure Pharmaceuticals Limited Details
        2.6.2 Finecure Pharmaceuticals Limited Major Business
        2.6.3 Finecure Pharmaceuticals Limited Hepatoprotective Drug Against Alcohol Product and Services
        2.6.4 Finecure Pharmaceuticals Limited Hepatoprotective Drug Against Alcohol Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Finecure Pharmaceuticals Limited Recent Developments/Updates
    2.7 Iscon Life Sciences
        2.7.1 Iscon Life Sciences Details
        2.7.2 Iscon Life Sciences Major Business
        2.7.3 Iscon Life Sciences Hepatoprotective Drug Against Alcohol Product and Services
        2.7.4 Iscon Life Sciences Hepatoprotective Drug Against Alcohol Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Iscon Life Sciences Recent Developments/Updates
    2.8 Sunflower Pharmaceutical Group Co.,ltd.
        2.8.1 Sunflower Pharmaceutical Group Co.,ltd. Details
        2.8.2 Sunflower Pharmaceutical Group Co.,ltd. Major Business
        2.8.3 Sunflower Pharmaceutical Group Co.,ltd. Hepatoprotective Drug Against Alcohol Product and Services
        2.8.4 Sunflower Pharmaceutical Group Co.,ltd. Hepatoprotective Drug Against Alcohol Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Sunflower Pharmaceutical Group Co.,ltd. Recent Developments/Updates
    2.9 Swisse
        2.9.1 Swisse Details
        2.9.2 Swisse Major Business
        2.9.3 Swisse Hepatoprotective Drug Against Alcohol Product and Services
        2.9.4 Swisse Hepatoprotective Drug Against Alcohol Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Swisse Recent Developments/Updates
    2.10 By-health Co.,ltd
        2.10.1 By-health Co.,ltd Details
        2.10.2 By-health Co.,ltd Major Business
        2.10.3 By-health Co.,ltd Hepatoprotective Drug Against Alcohol Product and Services
        2.10.4 By-health Co.,ltd Hepatoprotective Drug Against Alcohol Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 By-health Co.,ltd Recent Developments/Updates
    2.11 Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd.
        2.11.1 Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd. Details
        2.11.2 Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd. Major Business
        2.11.3 Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd. Hepatoprotective Drug Against Alcohol Product and Services
        2.11.4 Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd. Hepatoprotective Drug Against Alcohol Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd. Recent Developments/Updates
    2.12 Xiuzheng Pharmaceutical Industry Group Company
        2.12.1 Xiuzheng Pharmaceutical Industry Group Company Details
        2.12.2 Xiuzheng Pharmaceutical Industry Group Company Major Business
        2.12.3 Xiuzheng Pharmaceutical Industry Group Company Hepatoprotective Drug Against Alcohol Product and Services
        2.12.4 Xiuzheng Pharmaceutical Industry Group Company Hepatoprotective Drug Against Alcohol Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Xiuzheng Pharmaceutical Industry Group Company Recent Developments/Updates

3 Competitive Environment: Hepatoprotective Drug Against Alcohol by Manufacturer
    3.1 Global Hepatoprotective Drug Against Alcohol Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Hepatoprotective Drug Against Alcohol Revenue by Manufacturer (2018-2023)
    3.3 Global Hepatoprotective Drug Against Alcohol Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Hepatoprotective Drug Against Alcohol by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Hepatoprotective Drug Against Alcohol Manufacturer Market Share in 2022
        3.4.2 Top 6 Hepatoprotective Drug Against Alcohol Manufacturer Market Share in 2022
    3.5 Hepatoprotective Drug Against Alcohol Market: Overall Company Footprint Analysis
        3.5.1 Hepatoprotective Drug Against Alcohol Market: Region Footprint
        3.5.2 Hepatoprotective Drug Against Alcohol Market: Company Product Type Footprint
        3.5.3 Hepatoprotective Drug Against Alcohol Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Hepatoprotective Drug Against Alcohol Market Size by Region
        4.1.1 Global Hepatoprotective Drug Against Alcohol Sales Quantity by Region (2018-2029)
        4.1.2 Global Hepatoprotective Drug Against Alcohol Consumption Value by Region (2018-2029)
        4.1.3 Global Hepatoprotective Drug Against Alcohol Average Price by Region (2018-2029)
    4.2 North America Hepatoprotective Drug Against Alcohol Consumption Value (2018-2029)
    4.3 Europe Hepatoprotective Drug Against Alcohol Consumption Value (2018-2029)
    4.4 Asia-Pacific Hepatoprotective Drug Against Alcohol Consumption Value (2018-2029)
    4.5 South America Hepatoprotective Drug Against Alcohol Consumption Value (2018-2029)
    4.6 Middle East and Africa Hepatoprotective Drug Against Alcohol Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Hepatoprotective Drug Against Alcohol Sales Quantity by Type (2018-2029)
    5.2 Global Hepatoprotective Drug Against Alcohol Consumption Value by Type (2018-2029)
    5.3 Global Hepatoprotective Drug Against Alcohol Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Hepatoprotective Drug Against Alcohol Sales Quantity by Application (2018-2029)
    6.2 Global Hepatoprotective Drug Against Alcohol Consumption Value by Application (2018-2029)
    6.3 Global Hepatoprotective Drug Against Alcohol Average Price by Application (2018-2029)

7 North America
    7.1 North America Hepatoprotective Drug Against Alcohol Sales Quantity by Type (2018-2029)
    7.2 North America Hepatoprotective Drug Against Alcohol Sales Quantity by Application (2018-2029)
    7.3 North America Hepatoprotective Drug Against Alcohol Market Size by Country
        7.3.1 North America Hepatoprotective Drug Against Alcohol Sales Quantity by Country (2018-2029)
        7.3.2 North America Hepatoprotective Drug Against Alcohol Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Hepatoprotective Drug Against Alcohol Sales Quantity by Type (2018-2029)
    8.2 Europe Hepatoprotective Drug Against Alcohol Sales Quantity by Application (2018-2029)
    8.3 Europe Hepatoprotective Drug Against Alcohol Market Size by Country
        8.3.1 Europe Hepatoprotective Drug Against Alcohol Sales Quantity by Country (2018-2029)
        8.3.2 Europe Hepatoprotective Drug Against Alcohol Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Hepatoprotective Drug Against Alcohol Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Hepatoprotective Drug Against Alcohol Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Hepatoprotective Drug Against Alcohol Market Size by Region
        9.3.1 Asia-Pacific Hepatoprotective Drug Against Alcohol Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Hepatoprotective Drug Against Alcohol Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Hepatoprotective Drug Against Alcohol Sales Quantity by Type (2018-2029)
    10.2 South America Hepatoprotective Drug Against Alcohol Sales Quantity by Application (2018-2029)
    10.3 South America Hepatoprotective Drug Against Alcohol Market Size by Country
        10.3.1 South America Hepatoprotective Drug Against Alcohol Sales Quantity by Country (2018-2029)
        10.3.2 South America Hepatoprotective Drug Against Alcohol Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Hepatoprotective Drug Against Alcohol Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Hepatoprotective Drug Against Alcohol Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Hepatoprotective Drug Against Alcohol Market Size by Country
        11.3.1 Middle East & Africa Hepatoprotective Drug Against Alcohol Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Hepatoprotective Drug Against Alcohol Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Hepatoprotective Drug Against Alcohol Market Drivers
    12.2 Hepatoprotective Drug Against Alcohol Market Restraints
    12.3 Hepatoprotective Drug Against Alcohol Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
    13.1 Raw Material of Hepatoprotective Drug Against Alcohol and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Hepatoprotective Drug Against Alcohol
    13.3 Hepatoprotective Drug Against Alcohol Production Process
    13.4 Hepatoprotective Drug Against Alcohol Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Hepatoprotective Drug Against Alcohol Typical Distributors
    14.3 Hepatoprotective Drug Against Alcohol Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Hepatoprotective Drug Against Alcohol Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Hepatoprotective Drug Against Alcohol Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Livestamin Healthcare Basic Information, Manufacturing Base and Competitors
    Table 4. Livestamin Healthcare Major Business
    Table 5. Livestamin Healthcare Hepatoprotective Drug Against Alcohol Product and Services
    Table 6. Livestamin Healthcare Hepatoprotective Drug Against Alcohol Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. Livestamin Healthcare Recent Developments/Updates
    Table 8. The Himalaya Drug Company Basic Information, Manufacturing Base and Competitors
    Table 9. The Himalaya Drug Company Major Business
    Table 10. The Himalaya Drug Company Hepatoprotective Drug Against Alcohol Product and Services
    Table 11. The Himalaya Drug Company Hepatoprotective Drug Against Alcohol Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. The Himalaya Drug Company Recent Developments/Updates
    Table 13. Mysha Health World Basic Information, Manufacturing Base and Competitors
    Table 14. Mysha Health World Major Business
    Table 15. Mysha Health World Hepatoprotective Drug Against Alcohol Product and Services
    Table 16. Mysha Health World Hepatoprotective Drug Against Alcohol Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. Mysha Health World Recent Developments/Updates
    Table 18. Chambio Basic Information, Manufacturing Base and Competitors
    Table 19. Chambio Major Business
    Table 20. Chambio Hepatoprotective Drug Against Alcohol Product and Services
    Table 21. Chambio Hepatoprotective Drug Against Alcohol Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. Chambio Recent Developments/Updates
    Table 23. Noreva Biotech Basic Information, Manufacturing Base and Competitors
    Table 24. Noreva Biotech Major Business
    Table 25. Noreva Biotech Hepatoprotective Drug Against Alcohol Product and Services
    Table 26. Noreva Biotech Hepatoprotective Drug Against Alcohol Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. Noreva Biotech Recent Developments/Updates
    Table 28. Finecure Pharmaceuticals Limited Basic Information, Manufacturing Base and Competitors
    Table 29. Finecure Pharmaceuticals Limited Major Business
    Table 30. Finecure Pharmaceuticals Limited Hepatoprotective Drug Against Alcohol Product and Services
    Table 31. Finecure Pharmaceuticals Limited Hepatoprotective Drug Against Alcohol Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 32. Finecure Pharmaceuticals Limited Recent Developments/Updates
    Table 33. Iscon Life Sciences Basic Information, Manufacturing Base and Competitors
    Table 34. Iscon Life Sciences Major Business
    Table 35. Iscon Life Sciences Hepatoprotective Drug Against Alcohol Product and Services
    Table 36. Iscon Life Sciences Hepatoprotective Drug Against Alcohol Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 37. Iscon Life Sciences Recent Developments/Updates
    Table 38. Sunflower Pharmaceutical Group Co.,ltd. Basic Information, Manufacturing Base and Competitors
    Table 39. Sunflower Pharmaceutical Group Co.,ltd. Major Business
    Table 40. Sunflower Pharmaceutical Group Co.,ltd. Hepatoprotective Drug Against Alcohol Product and Services
    Table 41. Sunflower Pharmaceutical Group Co.,ltd. Hepatoprotective Drug Against Alcohol Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 42. Sunflower Pharmaceutical Group Co.,ltd. Recent Developments/Updates
    Table 43. Swisse Basic Information, Manufacturing Base and Competitors
    Table 44. Swisse Major Business
    Table 45. Swisse Hepatoprotective Drug Against Alcohol Product and Services
    Table 46. Swisse Hepatoprotective Drug Against Alcohol Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 47. Swisse Recent Developments/Updates
    Table 48. By-health Co.,ltd Basic Information, Manufacturing Base and Competitors
    Table 49. By-health Co.,ltd Major Business
    Table 50. By-health Co.,ltd Hepatoprotective Drug Against Alcohol Product and Services
    Table 51. By-health Co.,ltd Hepatoprotective Drug Against Alcohol Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 52. By-health Co.,ltd Recent Developments/Updates
    Table 53. Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
    Table 54. Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd. Major Business
    Table 55. Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd. Hepatoprotective Drug Against Alcohol Product and Services
    Table 56. Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd. Hepatoprotective Drug Against Alcohol Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 57. Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd. Recent Developments/Updates
    Table 58. Xiuzheng Pharmaceutical Industry Group Company Basic Information, Manufacturing Base and Competitors
    Table 59. Xiuzheng Pharmaceutical Industry Group Company Major Business
    Table 60. Xiuzheng Pharmaceutical Industry Group Company Hepatoprotective Drug Against Alcohol Product and Services
    Table 61. Xiuzheng Pharmaceutical Industry Group Company Hepatoprotective Drug Against Alcohol Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 62. Xiuzheng Pharmaceutical Industry Group Company Recent Developments/Updates
    Table 63. Global Hepatoprotective Drug Against Alcohol Sales Quantity by Manufacturer (2018-2023) & (K Units)
    Table 64. Global Hepatoprotective Drug Against Alcohol Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 65. Global Hepatoprotective Drug Against Alcohol Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 66. Market Position of Manufacturers in Hepatoprotective Drug Against Alcohol, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 67. Head Office and Hepatoprotective Drug Against Alcohol Production Site of Key Manufacturer
    Table 68. Hepatoprotective Drug Against Alcohol Market: Company Product Type Footprint
    Table 69. Hepatoprotective Drug Against Alcohol Market: Company Product Application Footprint
    Table 70. Hepatoprotective Drug Against Alcohol New Market Entrants and Barriers to Market Entry
    Table 71. Hepatoprotective Drug Against Alcohol Mergers, Acquisition, Agreements, and Collaborations
    Table 72. Global Hepatoprotective Drug Against Alcohol Sales Quantity by Region (2018-2023) & (K Units)
    Table 73. Global Hepatoprotective Drug Against Alcohol Sales Quantity by Region (2024-2029) & (K Units)
    Table 74. Global Hepatoprotective Drug Against Alcohol Consumption Value by Region (2018-2023) & (USD Million)
    Table 75. Global Hepatoprotective Drug Against Alcohol Consumption Value by Region (2024-2029) & (USD Million)
    Table 76. Global Hepatoprotective Drug Against Alcohol Average Price by Region (2018-2023) & (US$/Unit)
    Table 77. Global Hepatoprotective Drug Against Alcohol Average Price by Region (2024-2029) & (US$/Unit)
    Table 78. Global Hepatoprotective Drug Against Alcohol Sales Quantity by Type (2018-2023) & (K Units)
    Table 79. Global Hepatoprotective Drug Against Alcohol Sales Quantity by Type (2024-2029) & (K Units)
    Table 80. Global Hepatoprotective Drug Against Alcohol Consumption Value by Type (2018-2023) & (USD Million)
    Table 81. Global Hepatoprotective Drug Against Alcohol Consumption Value by Type (2024-2029) & (USD Million)
    Table 82. Global Hepatoprotective Drug Against Alcohol Average Price by Type (2018-2023) & (US$/Unit)
    Table 83. Global Hepatoprotective Drug Against Alcohol Average Price by Type (2024-2029) & (US$/Unit)
    Table 84. Global Hepatoprotective Drug Against Alcohol Sales Quantity by Application (2018-2023) & (K Units)
    Table 85. Global Hepatoprotective Drug Against Alcohol Sales Quantity by Application (2024-2029) & (K Units)
    Table 86. Global Hepatoprotective Drug Against Alcohol Consumption Value by Application (2018-2023) & (USD Million)
    Table 87. Global Hepatoprotective Drug Against Alcohol Consumption Value by Application (2024-2029) & (USD Million)
    Table 88. Global Hepatoprotective Drug Against Alcohol Average Price by Application (2018-2023) & (US$/Unit)
    Table 89. Global Hepatoprotective Drug Against Alcohol Average Price by Application (2024-2029) & (US$/Unit)
    Table 90. North America Hepatoprotective Drug Against Alcohol Sales Quantity by Type (2018-2023) & (K Units)
    Table 91. North America Hepatoprotective Drug Against Alcohol Sales Quantity by Type (2024-2029) & (K Units)
    Table 92. North America Hepatoprotective Drug Against Alcohol Sales Quantity by Application (2018-2023) & (K Units)
    Table 93. North America Hepatoprotective Drug Against Alcohol Sales Quantity by Application (2024-2029) & (K Units)
    Table 94. North America Hepatoprotective Drug Against Alcohol Sales Quantity by Country (2018-2023) & (K Units)
    Table 95. North America Hepatoprotective Drug Against Alcohol Sales Quantity by Country (2024-2029) & (K Units)
    Table 96. North America Hepatoprotective Drug Against Alcohol Consumption Value by Country (2018-2023) & (USD Million)
    Table 97. North America Hepatoprotective Drug Against Alcohol Consumption Value by Country (2024-2029) & (USD Million)
    Table 98. Europe Hepatoprotective Drug Against Alcohol Sales Quantity by Type (2018-2023) & (K Units)
    Table 99. Europe Hepatoprotective Drug Against Alcohol Sales Quantity by Type (2024-2029) & (K Units)
    Table 100. Europe Hepatoprotective Drug Against Alcohol Sales Quantity by Application (2018-2023) & (K Units)
    Table 101. Europe Hepatoprotective Drug Against Alcohol Sales Quantity by Application (2024-2029) & (K Units)
    Table 102. Europe Hepatoprotective Drug Against Alcohol Sales Quantity by Country (2018-2023) & (K Units)
    Table 103. Europe Hepatoprotective Drug Against Alcohol Sales Quantity by Country (2024-2029) & (K Units)
    Table 104. Europe Hepatoprotective Drug Against Alcohol Consumption Value by Country (2018-2023) & (USD Million)
    Table 105. Europe Hepatoprotective Drug Against Alcohol Consumption Value by Country (2024-2029) & (USD Million)
    Table 106. Asia-Pacific Hepatoprotective Drug Against Alcohol Sales Quantity by Type (2018-2023) & (K Units)
    Table 107. Asia-Pacific Hepatoprotective Drug Against Alcohol Sales Quantity by Type (2024-2029) & (K Units)
    Table 108. Asia-Pacific Hepatoprotective Drug Against Alcohol Sales Quantity by Application (2018-2023) & (K Units)
    Table 109. Asia-Pacific Hepatoprotective Drug Against Alcohol Sales Quantity by Application (2024-2029) & (K Units)
    Table 110. Asia-Pacific Hepatoprotective Drug Against Alcohol Sales Quantity by Region (2018-2023) & (K Units)
    Table 111. Asia-Pacific Hepatoprotective Drug Against Alcohol Sales Quantity by Region (2024-2029) & (K Units)
    Table 112. Asia-Pacific Hepatoprotective Drug Against Alcohol Consumption Value by Region (2018-2023) & (USD Million)
    Table 113. Asia-Pacific Hepatoprotective Drug Against Alcohol Consumption Value by Region (2024-2029) & (USD Million)
    Table 114. South America Hepatoprotective Drug Against Alcohol Sales Quantity by Type (2018-2023) & (K Units)
    Table 115. South America Hepatoprotective Drug Against Alcohol Sales Quantity by Type (2024-2029) & (K Units)
    Table 116. South America Hepatoprotective Drug Against Alcohol Sales Quantity by Application (2018-2023) & (K Units)
    Table 117. South America Hepatoprotective Drug Against Alcohol Sales Quantity by Application (2024-2029) & (K Units)
    Table 118. South America Hepatoprotective Drug Against Alcohol Sales Quantity by Country (2018-2023) & (K Units)
    Table 119. South America Hepatoprotective Drug Against Alcohol Sales Quantity by Country (2024-2029) & (K Units)
    Table 120. South America Hepatoprotective Drug Against Alcohol Consumption Value by Country (2018-2023) & (USD Million)
    Table 121. South America Hepatoprotective Drug Against Alcohol Consumption Value by Country (2024-2029) & (USD Million)
    Table 122. Middle East & Africa Hepatoprotective Drug Against Alcohol Sales Quantity by Type (2018-2023) & (K Units)
    Table 123. Middle East & Africa Hepatoprotective Drug Against Alcohol Sales Quantity by Type (2024-2029) & (K Units)
    Table 124. Middle East & Africa Hepatoprotective Drug Against Alcohol Sales Quantity by Application (2018-2023) & (K Units)
    Table 125. Middle East & Africa Hepatoprotective Drug Against Alcohol Sales Quantity by Application (2024-2029) & (K Units)
    Table 126. Middle East & Africa Hepatoprotective Drug Against Alcohol Sales Quantity by Region (2018-2023) & (K Units)
    Table 127. Middle East & Africa Hepatoprotective Drug Against Alcohol Sales Quantity by Region (2024-2029) & (K Units)
    Table 128. Middle East & Africa Hepatoprotective Drug Against Alcohol Consumption Value by Region (2018-2023) & (USD Million)
    Table 129. Middle East & Africa Hepatoprotective Drug Against Alcohol Consumption Value by Region (2024-2029) & (USD Million)
    Table 130. Hepatoprotective Drug Against Alcohol Raw Material
    Table 131. Key Manufacturers of Hepatoprotective Drug Against Alcohol Raw Materials
    Table 132. Hepatoprotective Drug Against Alcohol Typical Distributors
    Table 133. Hepatoprotective Drug Against Alcohol Typical Customers
List of Figures
    Figure 1. Hepatoprotective Drug Against Alcohol Picture
    Figure 2. Global Hepatoprotective Drug Against Alcohol Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Hepatoprotective Drug Against Alcohol Consumption Value Market Share by Type in 2022
    Figure 4. Based on Animal Ingredients Examples
    Figure 5. Based on Plant Ingredients Examples
    Figure 6. Global Hepatoprotective Drug Against Alcohol Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 7. Global Hepatoprotective Drug Against Alcohol Consumption Value Market Share by Application in 2022
    Figure 8. Pharmacy Examples
    Figure 9. Hospital Examples
    Figure 10. Dieticians Clinic Examples
    Figure 11. Supermarket Examples
    Figure 12. Others Examples
    Figure 13. Global Hepatoprotective Drug Against Alcohol Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 14. Global Hepatoprotective Drug Against Alcohol Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 15. Global Hepatoprotective Drug Against Alcohol Sales Quantity (2018-2029) & (K Units)
    Figure 16. Global Hepatoprotective Drug Against Alcohol Average Price (2018-2029) & (US$/Unit)
    Figure 17. Global Hepatoprotective Drug Against Alcohol Sales Quantity Market Share by Manufacturer in 2022
    Figure 18. Global Hepatoprotective Drug Against Alcohol Consumption Value Market Share by Manufacturer in 2022
    Figure 19. Producer Shipments of Hepatoprotective Drug Against Alcohol by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 20. Top 3 Hepatoprotective Drug Against Alcohol Manufacturer (Consumption Value) Market Share in 2022
    Figure 21. Top 6 Hepatoprotective Drug Against Alcohol Manufacturer (Consumption Value) Market Share in 2022
    Figure 22. Global Hepatoprotective Drug Against Alcohol Sales Quantity Market Share by Region (2018-2029)
    Figure 23. Global Hepatoprotective Drug Against Alcohol Consumption Value Market Share by Region (2018-2029)
    Figure 24. North America Hepatoprotective Drug Against Alcohol Consumption Value (2018-2029) & (USD Million)
    Figure 25. Europe Hepatoprotective Drug Against Alcohol Consumption Value (2018-2029) & (USD Million)
    Figure 26. Asia-Pacific Hepatoprotective Drug Against Alcohol Consumption Value (2018-2029) & (USD Million)
    Figure 27. South America Hepatoprotective Drug Against Alcohol Consumption Value (2018-2029) & (USD Million)
    Figure 28. Middle East & Africa Hepatoprotective Drug Against Alcohol Consumption Value (2018-2029) & (USD Million)
    Figure 29. Global Hepatoprotective Drug Against Alcohol Sales Quantity Market Share by Type (2018-2029)
    Figure 30. Global Hepatoprotective Drug Against Alcohol Consumption Value Market Share by Type (2018-2029)
    Figure 31. Global Hepatoprotective Drug Against Alcohol Average Price by Type (2018-2029) & (US$/Unit)
    Figure 32. Global Hepatoprotective Drug Against Alcohol Sales Quantity Market Share by Application (2018-2029)
    Figure 33. Global Hepatoprotective Drug Against Alcohol Consumption Value Market Share by Application (2018-2029)
    Figure 34. Global Hepatoprotective Drug Against Alcohol Average Price by Application (2018-2029) & (US$/Unit)
    Figure 35. North America Hepatoprotective Drug Against Alcohol Sales Quantity Market Share by Type (2018-2029)
    Figure 36. North America Hepatoprotective Drug Against Alcohol Sales Quantity Market Share by Application (2018-2029)
    Figure 37. North America Hepatoprotective Drug Against Alcohol Sales Quantity Market Share by Country (2018-2029)
    Figure 38. North America Hepatoprotective Drug Against Alcohol Consumption Value Market Share by Country (2018-2029)
    Figure 39. United States Hepatoprotective Drug Against Alcohol Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 40. Canada Hepatoprotective Drug Against Alcohol Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 41. Mexico Hepatoprotective Drug Against Alcohol Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 42. Europe Hepatoprotective Drug Against Alcohol Sales Quantity Market Share by Type (2018-2029)
    Figure 43. Europe Hepatoprotective Drug Against Alcohol Sales Quantity Market Share by Application (2018-2029)
    Figure 44. Europe Hepatoprotective Drug Against Alcohol Sales Quantity Market Share by Country (2018-2029)
    Figure 45. Europe Hepatoprotective Drug Against Alcohol Consumption Value Market Share by Country (2018-2029)
    Figure 46. Germany Hepatoprotective Drug Against Alcohol Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 47. France Hepatoprotective Drug Against Alcohol Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. United Kingdom Hepatoprotective Drug Against Alcohol Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 49. Russia Hepatoprotective Drug Against Alcohol Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 50. Italy Hepatoprotective Drug Against Alcohol Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 51. Asia-Pacific Hepatoprotective Drug Against Alcohol Sales Quantity Market Share by Type (2018-2029)
    Figure 52. Asia-Pacific Hepatoprotective Drug Against Alcohol Sales Quantity Market Share by Application (2018-2029)
    Figure 53. Asia-Pacific Hepatoprotective Drug Against Alcohol Sales Quantity Market Share by Region (2018-2029)
    Figure 54. Asia-Pacific Hepatoprotective Drug Against Alcohol Consumption Value Market Share by Region (2018-2029)
    Figure 55. China Hepatoprotective Drug Against Alcohol Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 56. Japan Hepatoprotective Drug Against Alcohol Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. Korea Hepatoprotective Drug Against Alcohol Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. India Hepatoprotective Drug Against Alcohol Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 59. Southeast Asia Hepatoprotective Drug Against Alcohol Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 60. Australia Hepatoprotective Drug Against Alcohol Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 61. South America Hepatoprotective Drug Against Alcohol Sales Quantity Market Share by Type (2018-2029)
    Figure 62. South America Hepatoprotective Drug Against Alcohol Sales Quantity Market Share by Application (2018-2029)
    Figure 63. South America Hepatoprotective Drug Against Alcohol Sales Quantity Market Share by Country (2018-2029)
    Figure 64. South America Hepatoprotective Drug Against Alcohol Consumption Value Market Share by Country (2018-2029)
    Figure 65. Brazil Hepatoprotective Drug Against Alcohol Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 66. Argentina Hepatoprotective Drug Against Alcohol Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 67. Middle East & Africa Hepatoprotective Drug Against Alcohol Sales Quantity Market Share by Type (2018-2029)
    Figure 68. Middle East & Africa Hepatoprotective Drug Against Alcohol Sales Quantity Market Share by Application (2018-2029)
    Figure 69. Middle East & Africa Hepatoprotective Drug Against Alcohol Sales Quantity Market Share by Region (2018-2029)
    Figure 70. Middle East & Africa Hepatoprotective Drug Against Alcohol Consumption Value Market Share by Region (2018-2029)
    Figure 71. Turkey Hepatoprotective Drug Against Alcohol Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 72. Egypt Hepatoprotective Drug Against Alcohol Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 73. Saudi Arabia Hepatoprotective Drug Against Alcohol Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 74. South Africa Hepatoprotective Drug Against Alcohol Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 75. Hepatoprotective Drug Against Alcohol Market Drivers
    Figure 76. Hepatoprotective Drug Against Alcohol Market Restraints
    Figure 77. Hepatoprotective Drug Against Alcohol Market Trends
    Figure 78. Porters Five Forces Analysis
    Figure 79. Manufacturing Cost Structure Analysis of Hepatoprotective Drug Against Alcohol in 2022
    Figure 80. Manufacturing Process Analysis of Hepatoprotective Drug Against Alcohol
    Figure 81. Hepatoprotective Drug Against Alcohol Industrial Chain
    Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 83. Direct Channel Pros & Cons
    Figure 84. Indirect Channel Pros & Cons
    Figure 85. Methodology
    Figure 86. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Hepatoprotective Drug Against Alcohol Supply, Demand and Key Producers, 2023-2029

Global Hepatoprotective Drug Against Alcohol Supply, Demand and Key Producers, 2023-2029

date 12 Feb 2023

date Pharma & Healthcare

The global Hepatoprotective Drug Against Alcohol market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Hepatoprotective Drug Against Alcohol Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Hepatoprotective Drug Against Alcohol Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Hepatoprotective Drug Against Alcohol market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

Hepatoprotective Drug Against Alcohol

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>